(Total Views: 221)
Posted On: 02/10/2021 11:09:22 AM
Post# of 44089
$TNXP a clinical-stage biopharmaceutical company, announced today that Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will participate in the BIO CEO & Investor Digital Conference being held February 16-18, 2021.
The Company’s presentation will be made through the BIO CEO & Investor Digital Conference website and available on demand to registered participants during the conference at https://www.bio.org/events/bio-ceo-investor-d...sentations. Following the conference, the presentation will be available under the IR Events tab of the Investors section of the Tonix website at www.tonixpharma.com.
https://markets.businessinsider.com/news/stoc...1030065915
The Company’s presentation will be made through the BIO CEO & Investor Digital Conference website and available on demand to registered participants during the conference at https://www.bio.org/events/bio-ceo-investor-d...sentations. Following the conference, the presentation will be available under the IR Events tab of the Investors section of the Tonix website at www.tonixpharma.com.
https://markets.businessinsider.com/news/stoc...1030065915
(0)
(0)
Cara Thera Low Float Stocks
https://i.makeagif.com/media/12-01-2018/6WgD08.mp4
https://i.makeagif.com/media/12-01-2018/6WgD08.mp4
